source
- Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concernsBristol Myers Squibb reported that a participant in its Phase 1 CAR-T study for multiple sclerosis died. The trial was testing an investigational CAR-T therapy aimed at autoimmune disease. The pat…
- Tango Therapeutics reports 82% tumor response in combo trial for advanced pancreatic cancerTango Therapeutics and Revolution Medicines presented data showing that their experimental combination therapy produced tumor responses in 82% of patients with a specific form of advanced pancreati…